Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
1988-10-11
|
pubmed:abstractText |
Clinical efficacy of 5 mg per 24 hours transdermal nitroglycerin was studied in a placebo controlled, randomized, double-blind crossover trial, with three days wash-out period at the beginning, in 40 patients with chronic stable angina pectoris during two periods of 14 days. Assessment was carried out by means of a diary method, by the multistage treadmill exercise test, five hours after dosing, and by 24-hour ambulatory ECG recordings. Nitroglycerin patch demonstrated significant improvement of exercise tolerance comparing to placebo, in exercise time to the onset of angina pectoris and ST-segment depression of greater than or equal to 1.0 mm (+45% and +47%), in maximum walking time (+13%), as well as in diminished severity of maximum angina (-38%), in lower maximal ST-segment depression (-32%) and in faster recovery of ST-depression 3 and 6 minutes after the test (-28% and -44%). Nitroglycerin patch showed 33% less angina attacks, mainly severe and moderate, resulting in 37% less sublingual nitroglycerin consumption. A significant fall in the number of ST-segment depression episodes of 1.5 mm or more (-60%) was shown in the 24-hour ECG. All these changes were confirmed to be significant compared to placebo values, at a level of P less than 0.01, by multivariate analysis. This study revealed a positive effect of low dose nitroglycerin patch on improvement of exercise functional capacity and signs of myocardial ischaemia after 14 days of continuous therapy.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0195-668X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
9 Suppl A
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
73-81
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:3137073-Administration, Cutaneous,
pubmed-meshheading:3137073-Adult,
pubmed-meshheading:3137073-Aged,
pubmed-meshheading:3137073-Angina Pectoris,
pubmed-meshheading:3137073-Clinical Trials as Topic,
pubmed-meshheading:3137073-Double-Blind Method,
pubmed-meshheading:3137073-Electrocardiography,
pubmed-meshheading:3137073-Exercise Test,
pubmed-meshheading:3137073-Female,
pubmed-meshheading:3137073-Humans,
pubmed-meshheading:3137073-Male,
pubmed-meshheading:3137073-Middle Aged,
pubmed-meshheading:3137073-Nitroglycerin,
pubmed-meshheading:3137073-Random Allocation
|
pubmed:year |
1988
|
pubmed:articleTitle |
A randomized placebo controlled, double-blind, crossover trial of transdermal nitroglycerin in stable angina pectoris.
|
pubmed:affiliation |
Department of Medicine, University Hospital Dr. O. Novosel, Faculty of Kinesiology, University of Zagreb, Yugoslavia.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial
|